Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, following the publication of the results of the ProtecT trial on localised prostate cancer diagnosis, what changes in diagnosis will be introduced for men aged between 50 and 69.
As the main aim of the ProtecT trial (Prostate testing for cancer and Treatment) is assessing mortality after 10 year follow-up, the full results of the trial are not expected to be known until 2017. Assessments on the impact of the results on changes to diagnosis will be made based on these results.